TGFB2 and glioblastoma: In a recent study, expression of a new generation OAd called Ad5 KT-E1A-IL-15 (TS-2021), along with Ki67 and TGF-β2 proteins, was generated to enable selective replication in GBM cells and enhance efficacy in killing GBM tumors (53).